ABBREVIATIONS LIST
Adherence, the extent to which patients' behaviors follow a recommended treatment path 1 , is widely 71 reported as being sub-optimal.
2 Chronic respiratory disease is no different -it is reported that between 72 30-50% of patients take treatment as prescribed. [3] [4] [5] This lack of adherence is not inconsequential; low 73 adherence is associated with treatment failure and poor health outcomes.
5-7 74
Many researchers have attempted to change adherence to prescribed treatments in chronic respiratory 75 disease by developing behavior change interventions. [8] [9] [10] [11] Medical Research Council (MRC) guidance 76 states that these interventions should be developed systematically and involve the use of behavior 77 change theories. 12 Yet studies of other complex interventions demonstrate that behavior change 78 theories are rarely used. 12, 13 The TIDieR reporting guidelines also recommend that the behavior change 79 theory used to design the intervention should be reported alongside a detailed description of what was 80 actually delivered (content) and how this was delivered (who provided the intervention, what was the 81 mode of delivery, where was it delivered, in what frequency and over what duration). 14 82 Systematic reviews of interventions to change adherence behavior in chronic respiratory disease have 83 synthesised the evidence for the effectiveness of these interventions.
2,15 But they have not focused 84 specifically on synthesising data on whether behavior change theories were used in their development, 85 nor have they explored the content or the delivery of these interventions. These data are needed to 86 inform the development of new interventions and to allow implementation of effective interventions 87 into clinical practice. This systematic review describes the behavior change theories used to develop 88 adherence interventions (compared to another intervention or usual care) in adults with chronic 89 respiratory disease, the content that was delivered, along with who provided it, its mode of delivery, 90
where it was delivered, in what frequency and over what duration. 91
MATERIALS AND METHODS 92

Inclusion and exclusion criteria for studies 93
We included randomized controlled trials (RCTs) of adults ≥ 18 years old, with a clinical diagnosis of 94 chronic respiratory disease (asthma, bronchiectasis, chronic obstructive pulmonary disease [COPD] March 2015 using the search strategy outlined in the online supplement. Language was restricted to 108
English. We searched the metaRegister of controlled trials (mRCT), ClinicalTrials.gov and the WHO trials 109 portal using the keywords 'adherence', 'compliance' and 'concordance.' 110
Study selection 111
Pairs of reviewers screened titles, abstracts and subsequent full texts (AMcC, CR, NY, CM, BON, JB, CH 112 plus three research assistants. All screeners received written instructions on screening from AMcC to 113 ensure consistency in approach (available on request from AMcC). Conflicts were resolved between 114 pairs and disagreements were resolved by a third reviewer (AMcC or CH). 115
Data extraction 116
Pairs of reviewers (AMcC and CR, NY and CM) extracted data on study design, participants and the 117 number of interventions tested (e.g. a three-arm study where two interventions were tested against 118 usual care would have two intervention arms). For each intervention, we extracted (from the abstract, 119 introduction, methods, results or discussion sections) the name of any behavior change theory used, the 120 unclear or low, using the Cochrane Collaboration's tool for assessing risk of bias) across six domains: 127 random sequence generation, allocation concealment, blinding of participants and personnel, blinding 128 of outcome assessment, incomplete outcome data, and selective reporting. 129
Synthesis of results and summary measures 130
Included studies could not be meta-analysed due to heterogeneity in the outcome measures used and 131 the interventions tested. Without meta-analysis, we could not determine the statistical importance of 132 theory, content and delivery using meta-regression. Consequently, we narratively described the 133 behavior change theories used in intervention development, and provided More than one clinician may have delivered a single intervention; each profession is counted separately. 140
We categorized interventions into "effective" (p<0.05 for adherence rate between groups), or 141 "ineffective" (p>0.05) by whether they were associated with statistically significant improvements in 142 objective adherence. 143
RESULTS 144
Summary of studies 145
Screening resulted in the inclusion of 46 studies (Figure 1 ) testing 58 interventions in 12,415 participants 146 (median 100 per study, range 12-6431) (e-Table 1-3). Most studies included patients with OSA or asthma 147 (Figure 1 ). Twenty-seven interventions (47%) were shown to be effective (e-Table 4-6). 148
Behavior change theory used in intervention development 149
Most (n=39, 67%) interventions were not based on behavior change theory (Figure 2 ). Nineteen 150 interventions (33%) (from 15 studies) were designed using 12 different behavior change theories (Table  151 1). A higher proportion of effective interventions (n=11, 41%) used behavior change theory to design 152 their intervention than ineffective interventions (n=8, 26%) (Figure 3) . 153
Content 154
Most (n=27, 47%) interventions delivered educational, self-management or supportive content (Figure  155 2). Educational, self-management or supportive content was more common for ineffective interventions 156 (n=17, 55%) than effective interventions (n=10, 37%) (Figure 3 ). Detailed descriptions of intervention 157 content are provided in eTable 1-3. 158
Delivery 159
The majority of interventions were delivered by doctors or nurses, on a face-to-face, one-to-one, out-160 patient basis across two to five visits, at various frequencies over the course of one to three months 161 (Figure 2 ). Doctors delivered a lower proportion of effective interventions (n=7, 18%) compared to 162 ineffective (n=13, 28%). Pharmacists delivered a higher proportion of effective (n=6, 15%) compared to 163 ineffective interventions (n=1, 2%). No other differences could be identified in who provided the 164 intervention, the mode of delivery, where was it delivered, in what frequency and over what duration. 165
Risk of Bias 166
Three studies had a low risk of bias. We rated the remaining studies as having an unclear or high risk of 167 bias in one or more domains (high risk in ≥1 domains, n=28; unclear risk in ≥1 domains, n=43) (Figure 4 , 168 e- Figure 1) . 169
170
DISCUSSION 171
Most adherence interventions did not use behavior change theories in their development. Of those that 172 did, they used 12 different behavior change theories. Use of behavior change theory was more common 173 amongst effective interventions. Most adherence interventions used educational and self-management 174 or supportive interventions delivered on a face-to-face, one-to-one out-patient basis (up to five visits, 175 one to three months). Interventions with educational, self-management or supportive content 176 constituted over half of ineffective interventions. Doctors delivered a lower proportion of the effective 177 interventions, and pharmacists a higher proportion of effective interventions (compared to ineffective 178 interventions). 179
One third of studies reported using behavior change theories in their development and more studies in 180 the effective interventions group used behavior change theory, adding weight to the recommendations 181 to use behavior change theory to design interventions.
12 Our findings are limited by the small number of 182 studies that reported using theory, and the extent to which these theories were used to inform the 183 intervention is not known. Given the poor reporting noted in behavior change interventions, it is also 184 possible that more studies used theory but did not report it. 16 Only self-efficacy theory and social 185 cognitive theory were used in more than one study. This is not surprising, given the range of behavior 186 change theories that exist. At the time that many of these interventions were designed, there was no 187 clear cut way of defining which theories to use and how to use them. Michie and colleagues have 188 attempted to remedy this issue by creating the Theoretical Domains Framework, in which they have 189 combined 128 explanatory constructs from 33 behavior change theories into a single framework of 14 190 domains. 13,20 191 Interventions using education, self-management or supportive approaches were more common 192 amongst ineffective interventions. The categories which were used to group content were broad and 193 the educational content varied greatly between studies, from group education 21 to patient advocates.
194
Defining intervention content and grouping similar interventions is a common challenge when reviewing 195 behavior change interventions and is a limitation of this review. This is due to the variety of 196 interventions used and is, in part, due to poor reporting of the exact content of interventions. 23 The 197 Behavior Change Technique (BCT) Taxonomy (published after this review commenced) attempts to 198 overcome this issue by defining the individual components of behavior change interventions in a 199 reproducible way by providing definitions and examples. 24 It has been used in other systematic reviews 200
to extract the components of existing interventions. 25 The main challenge with using this approach is 201 that the original intervention content was not designed to be defined by behavior change techniques 202 and is so poorly reported that is makes it nearly impossible to use this approach. 25 Future adherence 203 intervention studies should describe their interventions using the BCT Taxonomy 24 and report them 204 using reporting checklists such as TIDiER and CONSORT.
14,26 Many studies in this review reported study 205 designs and outcomes poorly; the use of these checklists would also address these issues. An adherence 206 intervention for bronchiectasis has been developed using this approach, and is currently under further 207 development prior to feasibility and pilot testing. Findings from this review demonstrated that a higher proportion of effective interventions were 209 delivered by pharmacists, and a lower proportion by doctors. It is possible that pharmacists have more 210 time, and receive more training on how to monitor and change adherence behaviour, or that those 211 interventions led by pharmacists contained components that specifically targeted the underlying 212 barriers and facilitators to adherence. No other differences in delivery were identified. It is likely thatthere is no 'one-size fits all' approach to intervention delivery and will depend on the healthcare context 214 in which the intervention is likely to be effective. 28 As an example, in cystic fibrosis, a group-based 215 primary care intervention delivered by a general practitioner and/or practice nurse is unlikely to be 216 effective given that most care is delivered by specialists in secondary care and patients are treated in 217 isolation of one another. In contrast, for COPD, this approach might be appropriate given that they 218 already receive annual reviews and have contact with their general practitioner and practice nurse (if in 219 the United Kingdom). Thus, researchers should involve stakeholders in intervention design to identify 220 the most appropriate delivery method for their patient population and healthcare context. have low adherence. [5] [6] [7] Research is beginning to focus on developing adherence interventions for these 224 groups 27, 30, 31 and this is an area for further development. 225
Our data show that the education, self-management and supportive approaches that may be commonly 226 used in clinical practice may not always be effective at improving adherence, and that using theory-227 based interventions may be more useful for clinicians to implement with patients. 228
Strengths of this review include: its broad scope, incorporating all adherence interventions across any 229 chronic respiratory disease or clinical setting, and the inclusion of studies reporting objective measures 230 of adherence. Comparisons between the use behavior change theory, content and delivery were 231 descriptive and based on small numbers of studies and should be interpreted with caution. The 232 heterogeneity of included interventions made categorization of intervention content problematic. We 233 only extracted data on adherence from final study visits, meaning any interim effects have not been 234 captured. Our search was restricted to English language and we did not contact authors to identify 235 unpublished studies, meaning the results presented could be affected by publication bias. We did not 236 extract any data on recruitment rates for individual studies which may affect the generalisability of the 237 findings presented. 238
Conclusion 239
Behavior change theory use was more common amongst effective interventions, providing evidence 240 that this in an important consideration for future adherence interventions. Social cognitive theory 35, 38, 19, 39, 40 Transtheoretical model 38 Triandis theory of behavior 41 "Theory-based" but specific theory not reported 42, 43 
